98 related articles for article (PubMed ID: 26374099)
1. Impact of delays in definitive treatment on overall survival: a National Cancer Database study of patients with Hodgkin lymphoma.
Parikh RR; Grossbard ML; Harrison LB; Yahalom J
Leuk Lymphoma; 2016 May; 57(5):1074-82. PubMed ID: 26374099
[TBL] [Abstract][Full Text] [Related]
2. Association of intensity-modulated radiation therapy on overall survival for patients with Hodgkin lymphoma.
Parikh RR; Grossbard ML; Harrison LB; Yahalom J
Radiother Oncol; 2016 Jan; 118(1):52-9. PubMed ID: 26522061
[TBL] [Abstract][Full Text] [Related]
3. Older patients with early-stage diffuse large B-cell lymphoma: the role of consolidation radiotherapy after chemoimmunotherapy.
Parikh RR; Yahalom J
Leuk Lymphoma; 2017 Mar; 58(3):614-622. PubMed ID: 27685446
[TBL] [Abstract][Full Text] [Related]
4. Early-Stage Classic Hodgkin Lymphoma: The Utilization of Radiation Therapy and Its Impact on Overall Survival.
Parikh RR; Grossbard ML; Harrison LB; Yahalom J
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):684-93. PubMed ID: 26279323
[TBL] [Abstract][Full Text] [Related]
5. Season of diagnosis is associated with overall survival in patients with diffuse large B-cell lymphoma but not with Hodgkin's lymphoma - A population-based Swedish Lymphoma Register study.
Székely E; Lindén O; Peterson S; Jerkeman M
Eur J Haematol; 2016 Oct; 97(4):393-8. PubMed ID: 26872557
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials.
Sasse S; Bröckelmann PJ; Goergen H; Plütschow A; Müller H; Kreissl S; Buerkle C; Borchmann S; Fuchs M; Borchmann P; Diehl V; Engert A
J Clin Oncol; 2017 Jun; 35(18):1999-2007. PubMed ID: 28418763
[TBL] [Abstract][Full Text] [Related]
7. Disparities in survival by insurance status in patients with Hodgkin lymphoma.
Parikh RR; Grossbard ML; Green BL; Harrison LB; Yahalom J
Cancer; 2015 Oct; 121(19):3515-24. PubMed ID: 26058564
[TBL] [Abstract][Full Text] [Related]
8. Association of Treatment Intensity With Survival in Older Patients With Hodgkin Lymphoma.
Rodday AM; Hahn T; Kumar AJ; Lindenauer PK; Friedberg JW; Evens AM; Parsons SK
JAMA Netw Open; 2021 Oct; 4(10):e2128373. PubMed ID: 34673965
[TBL] [Abstract][Full Text] [Related]
9. Impact of time from diagnosis to initiation of curative-intent chemotherapy on clinical outcomes in patients with classical Hodgkin lymphoma.
Brooks EG; Connors JM; Sehn LH; Gascoyne RD; Savage KJ; Shenkier TN; Klasa R; Gerrie AS; Skinnider B; Slack GW; Villa D
Leuk Lymphoma; 2016; 57(4):872-9. PubMed ID: 26325236
[TBL] [Abstract][Full Text] [Related]
10. Survival analysis of patients with Hodgkin lymphoma who failed high dose chemotherapy and autologous stem cell transplant.
Elshenawy MA; Shahzad Rauf M; Elhassan TAM; Maghfoor I; Akhtar S
Ann Hematol; 2018 Jul; 97(7):1229-1240. PubMed ID: 29484455
[TBL] [Abstract][Full Text] [Related]
11. Relapsed hodgkin lymphoma in older patients: a comprehensive analysis from the German hodgkin study group.
Böll B; Goergen H; Arndt N; Meissner J; Krause SW; Schnell R; von Tresckow B; Eichenauer DA; Sasse S; Fuchs M; Behringer K; Klimm BC; Naumann R; Diehl V; Engert A; Borchmann P
J Clin Oncol; 2013 Dec; 31(35):4431-7. PubMed ID: 24190119
[TBL] [Abstract][Full Text] [Related]
12. Time to initiation of adjuvant chemotherapy in patients with rapidly proliferating early breast cancer.
Farolfi A; Scarpi E; Rocca A; Mangia A; Biglia N; Gianni L; Tienghi A; Valerio MR; Gasparini G; Amaducci L; Faedi M; Baldini E; Rubagotti A; Maltoni R; Paradiso A; Amadori D
Eur J Cancer; 2015 Sep; 51(14):1874-81. PubMed ID: 26206258
[TBL] [Abstract][Full Text] [Related]
13. Adult nodular lymphocyte-predominant Hodgkin lymphoma: treatment modality utilization and survival.
Alonso C; Dutta SW; Mitra N; Landsburg DJ; Zaorsky NG; Grover S; Peterson J; Trifiletti DM
Cancer Med; 2018 Apr; 7(4):1118-1126. PubMed ID: 29479868
[TBL] [Abstract][Full Text] [Related]
14. Treatment selection and outcomes in early-stage classical Hodgkin lymphoma: analysis of the National Cancer Data Base.
Olszewski AJ; Shrestha R; Castillo JJ
J Clin Oncol; 2015 Feb; 33(6):625-33. PubMed ID: 25584010
[TBL] [Abstract][Full Text] [Related]
15. Early-stage nodular lymphocyte-predominant Hodgkin lymphoma: the impact of radiotherapy on overall survival.
Parikh RR; Grossbard ML; Harrison LB; Yahalom J
Leuk Lymphoma; 2016 Feb; 57(2):320-327. PubMed ID: 26110882
[TBL] [Abstract][Full Text] [Related]
16. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP
Borchmann P; Haverkamp H; Lohri A; Mey U; Kreissl S; Greil R; Markova J; Feuring-Buske M; Meissner J; Dührsen U; Ostermann H; Keller U; Maschmeyer G; Kuhnert G; Dietlein M; Kobe C; Eich H; Baues C; Stein H; Fuchs M; Diehl V; Engert A
Lancet Oncol; 2017 Apr; 18(4):454-463. PubMed ID: 28236583
[TBL] [Abstract][Full Text] [Related]
17. Risk factors predicting outcomes for primary refractory hodgkin lymphoma patients treated with salvage chemotherapy and autologous stem cell transplantation.
Shah GL; Yahalom J; Matasar MJ; Verwys SL; Goldman DA; Bantilan KS; Zhang Z; McCall SJ; Moskowitz AJ; Moskowitz CH
Br J Haematol; 2016 Nov; 175(3):440-447. PubMed ID: 27377168
[TBL] [Abstract][Full Text] [Related]
18. Lower socioeconomic status is independently associated with shorter survival in Hodgkin Lymphoma patients-An analysis from the Brazilian Hodgkin Lymphoma Registry.
Biasoli I; Castro N; Delamain M; Silveira T; Farley J; Pinto Simões B; Solza C; Praxedes M; Baiocchi O; Gaiolla R; Franceschi F; Bonamin Sola C; Boquimpani C; Clementino N; Fleury Perini G; Pagnano K; Steffenello G; Tabacof J; de Freitas Colli G; Soares A; de Souza C; Chiattone CS; Raggio Luiz R; Milito C; Morais JC; Spector N
Int J Cancer; 2018 Mar; 142(5):883-890. PubMed ID: 29023692
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy for patients with stage IV classical Hodgkin lymphoma: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
Wang S; Jia M; Han J; Zhang R; Huang K; Li P; Li Q; Qiao Y; Song Q; Fu Z
Cancer Biol Ther; 2020 Sep; 21(9):832-840. PubMed ID: 32835569
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of biological markers in paediatric Hodgkin lymphoma.
Farruggia P; Puccio G; Sala A; Todesco A; Buffardi S; Garaventa A; Bottigliero G; Bianchi M; Zecca M; Locatelli F; Pession A; Pillon M; Favre C; D'Amico S; Provenzi M; Trizzino A; Zanazzo GA; Sau A; Santoro N; Murgia G; Casini T; Mascarin M; Burnelli R;
Eur J Cancer; 2016 Jan; 52():33-40. PubMed ID: 26630532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
